A Multicenter Study of Unplanned Hospital Readmissions after Transsphenoidal Surgery for Cushing's Disease

Abstract

Objectives

Patients undergoing surgery for Cushing's disease may be more likely to be readmitted to the hospital than other patients with pituitary disorders. We investigated rates, causes, and predictors of unplanned readmission following transsphenoidal surgery for Cushing's disease to identify areas for clinical, financial, and administrative improvements.

Design

Retrospective cohort study.

Setting

Academic pituitary centers in the United States participating in a multicenter surgical outcome registry.

Participants

Five hundred and nineteen patients underwent transsphenoidal surgery for treatment of Cushing's disease by 26 surgeons at nine participating institutions from 2003 to 2023.

Main Outcome Measures

Unplanned 90-day readmission rates and causes of readmission.

Results

Unplanned readmissions occurred in 57/519 patients (11.0%), with hyponatremia in 12/57 (21%), cerebrospinal fluid leak evaluation in 8/57 (14%), epistaxis in 6/57 (10%), deep vein thrombosis in 4/57 (7%), syncope in 3/57 (5%), and headache in 3/57 (5%). Factors including no tumor on initial magnetic resonance imaging, return to the operating room during the index admission, lack of early remission, and inpatient complications were associated with a greater probability of readmission on univariate analysis. However, none remained predictive on multivariate analysis.

Conclusion

Our results show that readmission rates after transsphenoidal surgery for Cushing's disease are comparable to previously reported rates for all pituitary-related disorders, with the most common reason being hyponatremia. High-impact clinical protocols focused on preventing delayed hyponatremia may reduce the risk of readmission. Failure to identify significant predictors of readmission, even in this large clinical dataset, underscores the challenge of identifying high-risk clinical cohorts.

Keywords

body mass index - Cushing's disease - deep venous thrombosis - dyslipidemia - hyperglycemia - hyponatremia - pituitary

Previous Presentation

This work was presented at the North American Skull Base Society meeting in Atlanta, Georgia, February 16–19, 2024.

Publikationsverlauf

Eingereicht: 21. Februar 2024

Angenommen: 29. Juli 2024

Artikel online veröffentlicht:
20. August 2024

• References

• 1 Shaftel KA, Cole TS, Little AS. National trends in hospital readmission following transsphenoidal surgery for pituitary lesions. Pituitary 2020; 23 (02) 79-91
• 2 Younus I, Gerges MM, Dobri GA, Ramakrishna R, Schwartz TH. Readmission after endoscopic transsphenoidal pituitary surgery: analysis of 584 consecutive cases. J Neurosurg 2019; 133 (04) 1242-1247
• 3 Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing's syndrome: state of the art. Lancet Diabetes Endocrinol 2016; 4 (07) 611-629
• 4 Centers for Medicare & Medicaid Services. Hospital Readmissions Reduction Program (HRRP). Catalyst Carryover. 2018 ;4(2)
• 5 Hendricks BL, Shikary TA, Zimmer LA. Causes for 30-day readmission following transsphenoidal surgery. Otolaryngol Head Neck Surg 2016; 154 (02) 359-365
• 6 Ghiam MK, Chyou DE, Dable CL. et al. 30-day readmissions and coordination of care following endoscopic transsphenoidal pituitary surgery: experience with 409 patients. J Neurol Surg B Skull Base 2021; 83 (Suppl. 02) e410-e418
• 7 Little AS, Karsy M, Evans JJ. et al; RAPID Consortium. Multicenter Registry of Adenomas of the Pituitary and related Disorders: initial description of Cushing disease cohort, surgical outcomes, and surgeon characteristics. Neurosurgery 2024; 95 (02) 372-379
• 8 Bohl MA, Ahmad S, Jahnke H. et al. Delayed hyponatremia is the most common cause of 30-day unplanned readmission after transsphenoidal surgery for pituitary tumors. Neurosurgery 2016; 78 (01) 84-90
• 9 Vandenbroucke JP, von Elm E, Altman DG. et al; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007; 4 (10) e297
• 10 Rizvi ZH, Ferrandino R, Luu Q, Suh JD, Wang MB. Nationwide analysis of unplanned 30-day readmissions after transsphenoidal pituitary surgery. Int Forum Allergy Rhinol 2019; 9 (03) 322-329
• 11 Cote DJ, Dasenbrock HH, Muskens IS. et al. Readmission and other adverse events after transsphenoidal surgery: prevalence, timing, and predictive factors. J Am Coll Surg 2017; 224 (05) 971-979
• 12 Silva NA, Taylor BES, Herendeen JS, Reddy R, Eloy JA, Liu JK. Return to the emergency room with or without readmission after endoscopic transsphenoidal surgery in socioeconomically disadvantaged patients at an urban medical center. World Neurosurg 2018; 124: e131-e138
• 13 Pelargos PE, Hasanjee A, Lee B. et al. An institutional experience in applying quality improvement measures to pituitary surgery: clinical and resource implications. Neurosurg Focus 2023; 55 (06) E10
• 14 Cossu G, Belouaer A, Kloeckner J. et al. The Enhanced Recovery After Surgery protocol for the perioperative management of pituitary neuroendocrine tumors/pituitary adenomas. Neurosurg Focus 2023; 55 (06) E9
• 15 Bohl MA, Ahmad S, White WL, Little AS. Implementation of a postoperative outpatient care pathway for delayed hyponatremia following transsphenoidal surgery. Neurosurgery 2018; 82 (01) 110-117
• 16 Crabb BT, Hamrick F, Campbell JM. et al. Machine learning-based analysis and prediction of unplanned 30-day readmissions after pituitary adenoma resection: a multi-institutional retrospective study with external validation. Neurosurgery 2022; 91 (02) 263-271
• 17 Little AS, Chapple K. Predictors of resource utilization in transsphenoidal surgery for Cushing disease. J Neurosurg 2013; 119 (02) 504-511
• 18 Hunsaker J, Khan M, Makarenko S, Evans J, Couldwell W, Karsy M. Prediction of readmission and complications after pituitary adenoma resection via the National Surgical Quality Improvement Program (NSQIP) database. Cureus 2021; 13 (05) e14809